2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Community Pharmacists’ Knowledge and Attitude Towards Opioid Pain Medication Use in Bahir Dar City, North-West Ethiopia

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Opioid use is a major global public health problem, affecting 16 million individuals worldwide. According to a 2023 WHO report, out of the 600,000 substance-related deaths worldwide, 80% were attributed to opioid use. Pharmacists play a vital role in reducing unnecessary opioid exposure while facilitating access to non-opioid alternatives. To do so, pharmacists should have sufficient knowledge regarding opioid-containing medications and a positive attitude about opioid use problems.

          Objective

          This study aimed to evaluate community pharmacists’ knowledge of opioid-containing medications and their attitude toward opioid use problems.

          Materials and methods

          A cross-sectional study was conducted using a self-administered, structured questionnaire distributed to 105 community pharmacists from July 1–30, 2023 in Bahir Dar City, Ethiopia. The tool included demographic information and questions designed to assess participants’ knowledge and attitudes.

          Results

          Out of the 105 pharmacists included in this study, majority were males (54.3%), nearly half held a bachelor’s degree (49.5%), and slightly above one-third had over a decade experience (39%). Regarding knowledge and attitude towards opioids, 62 individuals (59%) exhibited good knowledge, and 64 (61%) demonstrated less stigma toward opioid usage. Factors affecting knowledge include: education level (AOR (95% CI): 8.43 (1.76–40.35) and 9.93 (1.04–85.33) for bachelors and postgraduates respectively and age 1.45 (1.20–1.77)]. Meanwhile, experience [AOR (95% CI): 4.64(1.20–17.90) and 4.29 (1.23–15.05)] for 5–9 years and ≥10 years respectively and education level [AOR (95% CI): 4.08 (1.40–11.93) for bachelors and 6.40 (1.42–28.96)] for postgraduates were linked to attitude.

          Conclusion

          A gap in knowledge and more stigmatizing behavior was observed among community pharmacists. These findings imply the importance of tailored educational interventions to address knowledge gaps and promote positive attitudes toward opioid usage among community pharmacists. Therefore, it is imperative to deliver up-to-date information on opioids, emphasizing their high addiction potential, to ensure pharmacists are well-equipped with the latest information.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: not found
          • Article: not found
          Is Open Access

          Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders

            The global rise in opioid-related harms has impacted the United States severely. Current efforts to manage the opioid crisis have prompted a re-evaluation of many of the existing roles in the healthcare system, in order to maximize their individual effects on reducing opioid-associated morbidity and preventing overdose deaths. As one of the most accessible healthcare professionals in the US, pharmacists are well-positioned to participate in such activities. Historically, US pharmacists have had a limited role in the surveillance and treatment of substance use disorders. This narrative review explores the literature describing novel programs designed to capitalize on the role of the community pharmacist in helping to reduce opioid-related harms, as well as evaluations of existing practices already in place in the US and elsewhere around the world. Specific approaches examined include strategies to facilitate pharmacist monitoring for problematic opioid use, to increase pharmacy-based harm reduction efforts (including naloxone distribution and needle exchange programs), and to involve community pharmacists in the dispensation of opioid agonist therapy (OAT). Each of these activities present a potential means to further engage pharmacists in the identification and treatment of opioid use disorders (OUDs). Through a careful examination of these approaches, we hope that new strategies can be adopted to leverage the unique role of the community pharmacist to help reduce opioid-related harms in the US.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Reducing stigma towards substance users through an educational intervention: harder than it looks.

              Stigma towards people with substance use disorders is pervasive and imbedded in our US culture. Prejudicial attitudes that are part of a health care practitioner's value system are a barrier to people accessing health care and substance use treatment. This study aimed to reduce stigmatizing attitudes of graduate health care professional students by implementing an innovative curriculum combining multiple teaching methods.
                Bookmark

                Author and article information

                Journal
                J Multidiscip Healthc
                J Multidiscip Healthc
                jmdh
                Journal of Multidisciplinary Healthcare
                Dove
                1178-2390
                27 February 2024
                2024
                : 17
                : 833-841
                Affiliations
                [1 ]Department of Pharmaceutics, College of Medicine and Health Sciences, Bahir Dar University , Bahir Dar, Amhara, Ethiopia
                [2 ]Department of Social Pharmacy, College of Medicine and Health Sciences, Bahir Dar University , Bahir Dar, Amhara, Ethiopia
                [3 ]Department of Pharmacology, College of Medicine and Health Sciences, Bahir Dar University , Bahir Dar, Amhara, Ethiopia
                [4 ]Department of Clinical Pharmacy, College of Medicine and Health Sciences, Bahir Dar University , Bahir Dar, Amhara, Ethiopia
                [5 ]Department of Pharmacognosy, College of Medicine and Health Sciences, Bahir Dar University , Bahir Dar, Amhara, Ethiopia
                [6 ]Department of Pediatrics and Child Health Nursing, College of Medicine and Health Sciences, Bahir Dar University , Bahir Dar, Amhara, Ethiopia
                [7 ]Department of Adult health Nursing, College of Medicine and Health Sciences, Bahir Dar University , Bahir Dar, Amhara, Ethiopia
                Author notes
                Correspondence: Chernet Tafere, Tel +251924524636, Email cheru004@gmail.com
                Author information
                http://orcid.org/0000-0001-7792-5704
                http://orcid.org/0000-0002-1758-348X
                http://orcid.org/0000-0002-3207-8369
                http://orcid.org/0000-0001-9384-7398
                http://orcid.org/0000-0003-4841-0861
                http://orcid.org/0000-0002-5143-1746
                http://orcid.org/0000-0003-2488-304X
                http://orcid.org/0000-0001-7120-6514
                http://orcid.org/0000-0002-6933-5875
                http://orcid.org/0000-0001-6350-4933
                http://orcid.org/0000-0003-4921-6526
                http://orcid.org/0000-0001-5122-7684
                http://orcid.org/0000-0003-3224-8409
                http://orcid.org/0000-0001-9737-4604
                Article
                452350
                10.2147/JMDH.S452350
                10908331
                38434484
                e825159e-dcde-4230-89aa-7040099932ac
                © 2024 Tafere et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 29 November 2023
                : 21 February 2024
                Page count
                Figures: 1, Tables: 3, References: 31, Pages: 9
                Categories
                Original Research

                Medicine
                opioids,pain management,community pharmacists,knowledge,attitude,ethiopia
                Medicine
                opioids, pain management, community pharmacists, knowledge, attitude, ethiopia

                Comments

                Comment on this article